| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 83970 |
|
11,577 |
10,142 |
$348K |
| 82728 |
|
14,926 |
13,280 |
$141K |
| 84466 |
|
14,795 |
13,244 |
$135K |
| 83540 |
|
14,814 |
13,251 |
$67K |
| 87340 |
|
6,034 |
5,317 |
$44K |
| 86803 |
|
11,825 |
11,132 |
$37K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
819 |
573 |
$22K |
| 86706 |
|
1,977 |
1,754 |
$15K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
8,363 |
7,904 |
$13K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
486 |
450 |
$11K |
| 80061 |
Lipid panel |
2,689 |
2,509 |
$7K |
| 86769 |
|
857 |
699 |
$7K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
488 |
327 |
$5K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
489 |
354 |
$3K |
| 86704 |
|
328 |
289 |
$2K |
| 82108 |
|
67 |
63 |
$1K |
| 84520 |
|
439 |
355 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
253 |
222 |
$541.02 |
| 84100 |
|
54 |
35 |
$194.13 |
| 84132 |
|
19 |
14 |
$152.44 |
| 82310 |
|
30 |
24 |
$137.68 |
| 87040 |
|
28 |
13 |
$82.66 |
| 84439 |
|
137 |
131 |
$40.14 |
| 80202 |
|
22 |
12 |
$25.08 |
| 85610 |
|
1,935 |
560 |
$5.51 |
| 80069 |
|
13 |
13 |
$0.94 |
| 85027 |
|
13 |
13 |
$0.74 |
| 84460 |
|
14 |
14 |
$0.56 |
| 84075 |
|
13 |
13 |
$0.56 |
| 84155 |
|
13 |
13 |
$0.40 |